Is the NHS ready for developments in cancer care? | Sponsored
The Politics Show
The New Statesman
4.2 • 1.5K Ratings
🗓️ 31 January 2024
⏱️ 24 minutes
🧾️ Download transcript
Summary
New technology means cancer diagnosis is better than ever.
Advances in genomic testing and other new technologies mean we are spotting cancer earlier, and getting better at identifying the best treatment for patients.
But a greater understanding of the disease – or group of diseases – means a requirement for more tailored treatment plans to improve patient outcomes. This involves challenges for the health service when it comes to capacity, cost, personnel, infrastructure, and expertise. Is the NHS ready?
In this special podcast, sponsored by Daiichi Sankyo, Becky Slack meets Karin Smyth, Labour’s Shadow Health Minister, Professor Clare Turnbull of the Institute for Cancer Research, and Dr. Marc Moodley, Medical Director of Oncology for Daiichi Sankyo. They explore what the new developments in cancer diagnostics and treatment mean for patients and the NHS, and discuss Labour’s plans for the health service.
This New Stateman podcast has been funded by and developed in partnership with Daiichi-Sankyo, a pharmaceutical company specialising in oncology and speciality medicines. For more information visit www.daiichi-sankyo.co.uk
--
To hear all our Spotlight on Policy podcast episodes, visit the standalone feed here: https://podfollow.com/spotlight-on-policy-from-the-new-statesman
Read more from the New Statesman's Spotlight on Policy team here: https://www.newstatesman.com/spotlight
LISTEN AD-FREE:
📱Download the New Statesman app
MORE FROM THE NEW STATESMAN:
❓ Ask a question – we answer them every Friday
⏰ Get our daily politics newsletter every morning
✍️ Enjoy the best of our writing via email every Saturday
Hosted on Acast. See acast.com/privacy for more information.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | The New Statesman Podcast. |
| 0:02.0 | The New Statesman. |
| 0:03.0 | Hello, you're listening to a special episode of the New Statesman podcast from the New Statesman Spotlight team, |
| 0:13.0 | week of a policy for those who shape it |
| 0:15.0 | and the businesses it affects. |
| 0:17.0 | I'm Becky Slack. |
| 0:19.0 | In this episode, we're discussing a vital issue that's facing the health service over the coming years |
| 0:25.1 | to treatment of cancer. The NHS and industry have made huge progress over the last decade in |
| 0:30.4 | cancer diagnostics and treatments. There have been so many success stories when it comes the potential for catching the disease early on |
| 0:37.0 | and paving the way for successful therapies. |
| 0:39.0 | But there are now even more rapid advances in the cancer treatment landscape. |
| 0:43.0 | Over the coming years it won't simply be seen in a brigboard cancer category |
| 0:48.0 | with some smaller subcategories like lung cancer. |
| 0:50.0 | Instead, given the advanced diagnostics and genomic testing we're now capable of, it will be more |
| 0:55.7 | accurate to look at cancer as a group of really rare diseases with smaller and smaller patient |
| 1:00.6 | populations. |
| 1:02.3 | That means that treatments too will be tailored |
| 1:04.5 | towards smaller and smaller groups of people and individuals. |
| 1:07.2 | These kinds of bespoke medicines are going to lead to vastly |
| 1:10.8 | improved patient outcomes. |
| 1:12.3 | Linked with all of this is the fact that there are lead to vastly improved patient outcomes. |
| 1:13.0 | Linked with all of this is the fact that there are whole new genomic |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The New Statesman, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The New Statesman and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.